Skip to main content
Professional Technical IVT

bempedoic acid

Pronunciation: bem-PED-oh-ik

An oral cholesterol-lowering medication that inhibits ATP citrate lyase, used as an alternative to statins.

Full Definition

Bempedoic acid is a first-in-class ATP citrate lyase inhibitor that reduces cholesterol synthesis upstream of HMG-CoA reductase, the target of statin therapy. It is administered orally and is particularly valuable for patients who cannot tolerate statins due to muscle-related side effects. The medication can be used alone or in combination with other lipid-lowering therapies. Clinical trials have demonstrated its efficacy in reducing LDL cholesterol and cardiovascular events, making it an important addition to the cardiovascular prevention armamentarium.

Usage

Usage note: Brand name Nexletol; often used in statin-intolerant patients.

In Context

  • "Bempedoic acid was initiated after the patient developed statin-associated myopathy with three different statin preparations." — Lipid management note

Also known as

ETC-1002

Don't confuse with

bile acid sequestrant

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON